Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

MTHFR gene polymorphisms and bladder cancer susceptibility: a meta-analysis including race, smoking status and tumour stage.

Kouidhi S, Rouissi K, Khedhiri S, Ouerhani S, Cherif M, Benammar-Elgaaied A.

Asian Pac J Cancer Prev. 2011;12(9):2227-32.

2.

MTHFR C677T and A1298C polymorphisms were associated with bladder cancer risk and disease progression: a meta-analysis.

You W, Li Z, Jing C, Qian-Wei X, Yu-Ping Z, Weng-Guang L, Hua-Lei L.

DNA Cell Biol. 2013 May;32(5):260-7. doi: 10.1089/dna.2012.1931. Epub 2013 Apr 11. Review.

PMID:
23578207
3.

Genetic susceptibility of methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C, and G1793A polymorphisms with risk for bladder transitional cell carcinoma in men.

Safarinejad MR, Shafiei N, Safarinejad S.

Med Oncol. 2011 Dec;28 Suppl 1:S398-412. doi: 10.1007/s12032-010-9723-9. Epub 2010 Oct 29.

PMID:
21046286
4.

Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control study.

Lin J, Spitz MR, Wang Y, Schabath MB, Gorlov IP, Hernandez LM, Pillow PC, Grossman HB, Wu X.

Carcinogenesis. 2004 Sep;25(9):1639-47. Epub 2004 Apr 29.

PMID:
15117811
5.

MTHFR C677T and A1298C polymorphisms and cervical carcinoma susceptibility: meta-analyses based on 4,421 individuals.

Zhuo WL, Zhang L, Ling JJ, Zhu Y, Chen ZT.

Mol Biol Rep. 2012 Sep;39(9):8723-32. doi: 10.1007/s11033-012-1732-7. Epub 2012 Jun 19.

PMID:
22711309
6.

Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls.

Qi X, Ma X, Yang X, Fan L, Zhang Y, Zhang F, Chen L, Zhou Y, Jiang J.

Breast Cancer Res Treat. 2010 Sep;123(2):499-506. doi: 10.1007/s10549-010-0773-7. Epub 2010 Feb 5.

PMID:
20135343
7.

Association between MTHFR gene polymorphisms (C677T, A1298C) and genetic susceptibility to prostate cancer: a meta-analysis.

Chen PL, Li WT, Wang J, Jiang YD, Wu P, Chen T, Zheng SB.

Genet Mol Res. 2015 Dec 29;14(4):19191-202. doi: 10.4238/2015.December.29.29.

8.

Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and susceptibility to gastric adenocarcinoma in an Italian population.

Boccia S, Gianfagna F, Persiani R, La Greca A, Arzani D, Rausei S, D'ugo D, Magistrelli P, Villari P, Van Duijn CM, Ricciardi G.

Biomarkers. 2007 Nov-Dec;12(6):635-44.

PMID:
17972183
9.

Relationships among MTHFR a1298c gene polymorphisms and methylation status of Dact1 gene in transitional cell carcinomas.

Cheng H, Lu M, Mao LJ, Wang JQ, Li W, Wen RM, Chen JC.

Asian Pac J Cancer Prev. 2012;13(10):5069-74.

10.

MTHFR polymorphisms and ovarian cancer risk: a meta-analysis.

Liu L, Liao SG, Wang YJ.

Mol Biol Rep. 2012 Nov;39(11):9863-8. Epub 2012 Jul 19.

PMID:
22810649
11.

Associations between C677T and A1298C polymorphisms of MTHFR and susceptibility to rheumatoid arthritis: a systematic review and meta-analysis.

Yuan Y, Shao W, Li Y.

Rheumatol Int. 2017 Apr;37(4):557-569. doi: 10.1007/s00296-017-3650-4. Epub 2017 Feb 7.

PMID:
28175955
12.
13.

Association between MTHFR C677T, MTHFR A1298C and MS A2756G polymorphisms and risk of cervical intraepithelial neoplasia II/III and cervical cancer: a meta-analysis.

Zhu J, Wu L, Kohlmeier M, Ye F, Cai W.

Mol Med Rep. 2013 Sep;8(3):919-27. doi: 10.3892/mmr.2013.1589. Epub 2013 Jul 16.

PMID:
23864153
14.

Genetic polymorphisms of methylenetetrahydrofolate reductase and susceptibility to colorectal cancer.

Cao HX, Gao CM, Takezaki T, Wu JZ, Ding JH, Liu YT, Li SP, Su P, Cao J, Hamajima N, Tajima K.

Asian Pac J Cancer Prev. 2008 Apr-Jun;9(2):203-8.

15.
16.

Allele and Genotype Frequencies of the Polymorphic Methylenetetrahydrofolate Reductase and Lung Cancer in ther Jordanian Population: a Case Control Study.

Al-Motassem Y, Shomaf M, Said I, Berger S, Ababneh N, Diab O, Obeidat N, Awidi A.

Asian Pac J Cancer Prev. 2015;16(8):3101-9.

17.

Association between MTHFR gene polymorphisms and the risk of autism spectrum disorders: a meta-analysis.

Pu D, Shen Y, Wu J.

Autism Res. 2013 Oct;6(5):384-92. doi: 10.1002/aur.1300. Epub 2013 May 7.

PMID:
23653228
18.

MTHFR gene polymorphisms in bladder cancer in the Turkish population.

Izmirli M, Inandiklioglu N, Abat D, Alptekin D, Demirhan O, Tansug Z, Bayazit Y.

Asian Pac J Cancer Prev. 2011;12(7):1833-5.

19.

Meta-analysis of MTHFR C677T and A1298C gene polymorphisms: association with the risk of hepatocellular carcinoma.

Qi YH, Yao LP, Cui GB, Liang J, Shao QJ, Yan LF, Du P.

Clin Res Hepatol Gastroenterol. 2014 Apr;38(2):172-80. doi: 10.1016/j.clinre.2013.10.002. Epub 2013 Dec 6. Review.

PMID:
24316043
20.

Methylenetetrahydrofolate reductase and methionine synthase polymorphisms and risk of bladder cancer in a Tunisian population.

Ouerhani S, Oliveira E, Marrakchi R, Ben Slama MR, Sfaxi M, Ayed M, Chebil M, Amorim A, El Gaaied AB, Prata MJ.

Cancer Genet Cytogenet. 2007 Jul 1;176(1):48-53.

PMID:
17574963

Supplemental Content

Support Center